Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity

NeuroReport

Volumn 15, Issue 2, 2004, Pages 263-266

  Xu, Yun ^a,b   Tao, Yuan Xiang ^b,c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell culture; Neuronal death; Nitric oxide; NMDA receptor; PAF

Indexed keywords

DIZOCILPINE; GINKGOLIDE B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; MOLECULAR MECHANICS; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ANIMALS; BRAIN ISCHEMIA; CELL DEATH; CELLS, CULTURED; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; GINKGOLIDES; LACTONES; MICE; NERVE DEGENERATION; NEURONS; NEUROTOXINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLATELET ACTIVATING FACTOR; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 1542320274     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200402090-00010     Document Type: Article

References (23)

1. Yue TL and Feuerstein GZ. Platelet-activating factor: a putative neuromodulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol 8, 11-24 (1994).
2. Clark GD, Happel LT, Zorumski CF and Bazan NG. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9, 1211-1216 (1992).
3. Marcheselli VL, Rossowska MJ, Domingo MT, Braquet P and Bazan NG. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem 265, 9140-9145 (1990).
4. Teather LA, Packard MG and Bazan NG. Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. Neurobiol Learn Mem 75, 310-324 (2001).
5. Bazan NG, Zorumski CF and Clark GD. The activation of phospholipase A2 and release of arachidonic acid and other lipid mediators at the synapse: the role of platelet-activating factor. J Lipid Mediat 6, 421-427 (1993).
6. Marcheselli VL and Bazan NG. Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus. J Neurosci Res 37, 54-61 (1994).
7. Braquet P, Paubert-Braquet M, Koltai M, Bourgain R, Bussolino F and Hosford. Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol Sci 10, 23-30 (1989).
8. Souza DG, Pinho V, Soares AC, Shimizu T, Ishii S and Teixeira MM. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol 139, 733-740 (2003).
9. Kato K, Clark GD, Bazan NG and Zorumski CF. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367, 175-179 (1994).
10. Tong N, Sanchez JF, Maggirwar SB, Ramirez SH, Guo H, Dewhurst S and Gelbard HA. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13, 1913-1922 (2001).
11. Sattler R and Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24, 107-129 (2001).
12. Tao Y-X, Rumbaugh G, Wang G, Petralia RS, Zhao C, Kauer FW et al. Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein. J Neurosci 23, 6703-6712 (2003).
13. Brewer C, Bonin F, Bullock P, Nault MC, Morin J, Imbeault S et al. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J Neurochem 82, 1502-1511 (2002).
14. Zhuang H, Koehler R and Dore S. Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann NY Acad Sci 993, 276-286 (2003).
15. McCollum AT, Nasr P and Estus S. Calpain activates caspase-3 during UV-induced neuronal death but only calpain is necessary for death. J Neurochem 82, 1208-1220 (2002).
16. Tao F, Tao Y-X, Mao P, Zhao C, Li D, Liaw WJ et al. Intact carrageenan-induced thermal hyperalgesia in mice lacking inducible nitric oxide synthase. Neuroscience 120, 847-854 (2003).
17. Snyder SH. Nitric oxide: first in a new class of neurotransmitters. Science 41, 494-496 (1992).
18. Calcerrada MC, Catalan RE and Martinez AM. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. Biochem Mol Biol Int 47, 529-535 (1999).
19. Nogami K, Hirashima Y, Endo S and Takaku A. Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures. Brain Res 754, 72-78 (1999).
20. Aihara M, Ishii S, Kume N and Shimizu T. Interaction between neurone and microglia mediated by platelet-activating factor. Genes Cells 5, 397-406 (2000).
21. Ogden F, DeCoster MA and Bazan NG. Recombinant plasma-type platelet-activating factor acetylhydrolase attenuates NMDA-induced hippocampal neuronal apoptosis. J Neurosci Res 53, 677-684 (1998).
22. Bazan NG, Rodriguez de Turco EB and Allan G. Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J Neurotrauma 12, 791-814 (1995).
23. Bazan NG and Allan G. Platelet-activating factor in the modulation of excitatory amino acid neurotransmitter release and of gene expression. J Lipid Mediat Cell Signal 14, 321-330 (1996).